Legal Representation
Attorney
Jonathan M. Gelchinsky
USPTO Deadlines
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 26, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 26, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 1, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 31, 2018 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Dec 14, 2018 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Dec 31, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 14, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 23, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 23, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 22, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 20, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 20, 2018 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 20, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 4, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 2, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 2, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 2, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 16, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 16, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 18, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 14, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 14, 2017 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 14, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 25, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 23, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 23, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 23, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 26, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 31, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 31, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 11, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 19, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 19, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 19, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 19, 2016 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 19, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 19, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 12, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 7, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; Design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"